KR101563017B1 - 불활성화된 내인성 유전자좌를 갖는 트랜스제닉 닭 - Google Patents
불활성화된 내인성 유전자좌를 갖는 트랜스제닉 닭 Download PDFInfo
- Publication number
- KR101563017B1 KR101563017B1 KR1020107005724A KR20107005724A KR101563017B1 KR 101563017 B1 KR101563017 B1 KR 101563017B1 KR 1020107005724 A KR1020107005724 A KR 1020107005724A KR 20107005724 A KR20107005724 A KR 20107005724A KR 101563017 B1 KR101563017 B1 KR 101563017B1
- Authority
- KR
- South Korea
- Prior art keywords
- pgc
- cells
- gene
- transgene
- site
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 232
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 96
- 241000287828 Gallus gallus Species 0.000 title claims description 189
- 235000013330 chicken meat Nutrition 0.000 title claims description 164
- 108700019146 Transgenes Proteins 0.000 claims abstract description 165
- 238000003822 preparative gas chromatography Methods 0.000 claims abstract description 73
- 210000002257 embryonic structure Anatomy 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 39
- 230000014509 gene expression Effects 0.000 claims description 73
- 210000001161 mammalian embryo Anatomy 0.000 claims description 63
- 210000004602 germ cell Anatomy 0.000 claims description 60
- 239000003550 marker Substances 0.000 claims description 40
- 230000008685 targeting Effects 0.000 claims description 37
- 210000001173 gonocyte Anatomy 0.000 claims description 28
- 238000012217 deletion Methods 0.000 claims description 14
- 230000037430 deletion Effects 0.000 claims description 14
- 230000012447 hatching Effects 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 11
- 238000009395 breeding Methods 0.000 claims description 5
- 230000001488 breeding effect Effects 0.000 claims description 5
- 108020004705 Codon Proteins 0.000 claims description 3
- 101150111062 C gene Proteins 0.000 claims description 2
- 101150008942 J gene Proteins 0.000 claims description 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 1
- 210000002980 germ line cell Anatomy 0.000 claims 1
- 230000006798 recombination Effects 0.000 abstract description 69
- 238000005215 recombination Methods 0.000 abstract description 69
- 210000002149 gonad Anatomy 0.000 abstract description 46
- 102000004169 proteins and genes Human genes 0.000 abstract description 44
- 102100034343 Integrase Human genes 0.000 abstract description 31
- 108010061833 Integrases Proteins 0.000 abstract description 31
- 238000012239 gene modification Methods 0.000 abstract description 27
- 230000005017 genetic modification Effects 0.000 abstract description 24
- 235000013617 genetically modified food Nutrition 0.000 abstract description 24
- 230000010354 integration Effects 0.000 abstract description 22
- 230000002779 inactivation Effects 0.000 abstract description 20
- 241000271566 Aves Species 0.000 abstract description 17
- 238000003776 cleavage reaction Methods 0.000 abstract description 15
- 230000007017 scission Effects 0.000 abstract description 14
- 230000002068 genetic effect Effects 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 7
- 230000035772 mutation Effects 0.000 abstract description 6
- 230000002035 prolonged effect Effects 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 377
- 108020004414 DNA Proteins 0.000 description 159
- 239000012634 fragment Substances 0.000 description 90
- 101150036876 cre gene Proteins 0.000 description 72
- 239000013598 vector Substances 0.000 description 64
- 238000003780 insertion Methods 0.000 description 61
- 230000037431 insertion Effects 0.000 description 61
- 210000001519 tissue Anatomy 0.000 description 57
- 239000013612 plasmid Substances 0.000 description 47
- 241001465754 Metazoa Species 0.000 description 46
- 101000607560 Homo sapiens Ubiquitin-conjugating enzyme E2 variant 3 Proteins 0.000 description 43
- 102100039936 Ubiquitin-conjugating enzyme E2 variant 3 Human genes 0.000 description 43
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 40
- 102000007469 Actins Human genes 0.000 description 32
- 108010085238 Actins Proteins 0.000 description 32
- 210000000349 chromosome Anatomy 0.000 description 32
- 239000000047 product Substances 0.000 description 31
- 238000003032 molecular docking Methods 0.000 description 29
- 238000001890 transfection Methods 0.000 description 29
- 238000004458 analytical method Methods 0.000 description 27
- 238000004113 cell culture Methods 0.000 description 27
- 239000000523 sample Substances 0.000 description 27
- 230000002710 gonadal effect Effects 0.000 description 26
- 238000002105 Southern blotting Methods 0.000 description 24
- 230000001404 mediated effect Effects 0.000 description 23
- 206010057190 Respiratory tract infections Diseases 0.000 description 22
- 241000287826 Gallus Species 0.000 description 21
- 229930193140 Neomycin Natural products 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 229960004927 neomycin Drugs 0.000 description 21
- 238000012546 transfer Methods 0.000 description 21
- 108010051219 Cre recombinase Proteins 0.000 description 20
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 20
- 229950010131 puromycin Drugs 0.000 description 19
- 239000012212 insulator Substances 0.000 description 18
- 241000195493 Cryptophyta Species 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 17
- 230000007774 longterm Effects 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 238000011161 development Methods 0.000 description 15
- 230000018109 developmental process Effects 0.000 description 15
- 230000001850 reproductive effect Effects 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 241000894007 species Species 0.000 description 14
- 235000013601 eggs Nutrition 0.000 description 13
- 238000004520 electroporation Methods 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- 101150090523 DAZL gene Proteins 0.000 description 12
- 241000700605 Viruses Species 0.000 description 12
- 239000012528 membrane Substances 0.000 description 12
- 230000000392 somatic effect Effects 0.000 description 12
- 241000713666 Lentivirus Species 0.000 description 11
- 239000004677 Nylon Substances 0.000 description 11
- 238000002744 homologous recombination Methods 0.000 description 11
- 230000006801 homologous recombination Effects 0.000 description 11
- 229920001778 nylon Polymers 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 238000012216 screening Methods 0.000 description 10
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000001671 embryonic stem cell Anatomy 0.000 description 9
- 230000006698 induction Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000002792 vascular Effects 0.000 description 9
- 101710098213 Beta-1,3-glucan-binding protein Proteins 0.000 description 8
- 108010077544 Chromatin Proteins 0.000 description 8
- 206010027476 Metastases Diseases 0.000 description 8
- 229930189065 blasticidin Natural products 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 210000003483 chromatin Anatomy 0.000 description 8
- 239000002299 complementary DNA Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 230000009401 metastasis Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 238000002054 transplantation Methods 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 7
- 102000002322 Egg Proteins Human genes 0.000 description 7
- 108010000912 Egg Proteins Proteins 0.000 description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 230000007547 defect Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000001568 sexual effect Effects 0.000 description 7
- 108091029523 CpG island Proteins 0.000 description 6
- 102100028572 Disabled homolog 2 Human genes 0.000 description 6
- 108091029865 Exogenous DNA Proteins 0.000 description 6
- 101000866272 Homo sapiens Double C2-like domain-containing protein alpha Proteins 0.000 description 6
- 108010017842 Telomerase Proteins 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 230000016784 immunoglobulin production Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 102100026608 Aldehyde dehydrogenase family 3 member A2 Human genes 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 210000003101 oviduct Anatomy 0.000 description 5
- 230000002062 proliferating effect Effects 0.000 description 5
- 230000000644 propagated effect Effects 0.000 description 5
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 4
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 241000286209 Phasianidae Species 0.000 description 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000010363 gene targeting Methods 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 230000001177 retroviral effect Effects 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 208000031639 Chromosome Deletion Diseases 0.000 description 3
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 3
- 108010001132 DNA Polymerase beta Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 3
- 101001035782 Gallus gallus Hemoglobin subunit beta Proteins 0.000 description 3
- 101000717967 Homo sapiens Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 108010052160 Site-specific recombinase Proteins 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 239000003636 conditioned culture medium Substances 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003746 feather Anatomy 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- -1 for example Proteins 0.000 description 3
- 230000030279 gene silencing Effects 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000001259 mesencephalon Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003153 stable transfection Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 101710130646 Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 2
- 102100033973 Anaphase-promoting complex subunit 10 Human genes 0.000 description 2
- 241000269350 Anura Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 102000001996 DNA Polymerase beta Human genes 0.000 description 2
- 238000012270 DNA recombination Methods 0.000 description 2
- OAUWKHSGCCPXOD-UHFFFAOYSA-N DOC1 Natural products C1=CC(O)=C2C(CC(=O)NCCCCCNCCCNCCCNCCCN)=CNC2=C1 OAUWKHSGCCPXOD-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000009701 Embryo Loss Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 108010046276 FLP recombinase Proteins 0.000 description 2
- 101000779315 Homo sapiens Anaphase-promoting complex subunit 10 Proteins 0.000 description 2
- 101000737813 Homo sapiens Cyclin-dependent kinase 2-associated protein 1 Proteins 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- 108010025815 Kanamycin Kinase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 241001272720 Medialuna californiensis Species 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 241000701955 Streptomyces virus phiC31 Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 102000006646 aminoglycoside phosphotransferase Human genes 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 210000001172 blastoderm Anatomy 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 108700017203 chicken ERNI Proteins 0.000 description 2
- 230000008711 chromosomal rearrangement Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000008380 degradant Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000005549 size reduction Methods 0.000 description 2
- 230000000920 spermatogeneic effect Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 101710159080 Aconitate hydratase A Proteins 0.000 description 1
- 101710159078 Aconitate hydratase B Proteins 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 241000269332 Ambystoma mexicanum Species 0.000 description 1
- 108010083359 Antigen Receptors Proteins 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 238000002883 ClustalW sequence alignment Methods 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 102100033672 Deleted in azoospermia-like Human genes 0.000 description 1
- 208000035976 Developmental Disabilities Diseases 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 108700028674 Drosophila vas Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 101150066002 GFP gene Proteins 0.000 description 1
- 101100231735 Gallus gallus HPRT1 gene Proteins 0.000 description 1
- 208000034951 Genetic Translocation Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 101000871280 Homo sapiens Deleted in azoospermia-like Proteins 0.000 description 1
- 101001127531 Homo sapiens Gastricsin Proteins 0.000 description 1
- 108700029227 Immunoglobulin Light Chain Genes Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010008364 Melanocortins Proteins 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 101100407657 Mus musculus Pgc gene Proteins 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- HPFXACZRFJDURI-KTKRTIGZSA-N N-oleoylglycine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCC(O)=O HPFXACZRFJDURI-KTKRTIGZSA-N 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- 241001045988 Neogene Species 0.000 description 1
- 101100329389 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cre-1 gene Proteins 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102100024770 Probable ATP-dependent RNA helicase DDX4 Human genes 0.000 description 1
- 101710136296 Probable ATP-dependent RNA helicase DDX4 Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 101710105008 RNA-binding protein Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- WZSDNEJJUSYNSG-UHFFFAOYSA-N azocan-1-yl-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CCCCCCC2)=C1 WZSDNEJJUSYNSG-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 108010047153 bovine corneal protein 54 Proteins 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 231100001129 embryonic lethality Toxicity 0.000 description 1
- 210000004212 embryonic organizer Anatomy 0.000 description 1
- 108700005856 engrailed 2 Proteins 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006718 epigenetic regulation Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000007045 gastrulation Effects 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 102000050250 human PGC Human genes 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021005 inheritance pattern Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000002473 insulinotropic effect Effects 0.000 description 1
- 230000003426 interchromosomal effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 210000003794 male germ cell Anatomy 0.000 description 1
- 210000003809 male germ line stem cell Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002865 melanocortin Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 101150091879 neo gene Proteins 0.000 description 1
- 210000000478 neocortex Anatomy 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000002804 pyramidal tract Anatomy 0.000 description 1
- 108091035233 repetitive DNA sequence Proteins 0.000 description 1
- 102000053632 repetitive DNA sequence Human genes 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000001743 silencing effect Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/30—Bird
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96489107P | 2007-08-14 | 2007-08-14 | |
US60/964,891 | 2007-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100088125A KR20100088125A (ko) | 2010-08-06 |
KR101563017B1 true KR101563017B1 (ko) | 2015-10-23 |
Family
ID=40351167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020107005724A KR101563017B1 (ko) | 2007-08-14 | 2008-08-14 | 불활성화된 내인성 유전자좌를 갖는 트랜스제닉 닭 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2187732A4 (ja) |
JP (3) | JP5760159B2 (ja) |
KR (1) | KR101563017B1 (ja) |
CN (1) | CN101868144A (ja) |
AU (1) | AU2008286791A1 (ja) |
CA (1) | CA2706224A1 (ja) |
WO (1) | WO2009023800A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012162422A2 (en) * | 2011-05-24 | 2012-11-29 | Crystal Bioscience Inc. | Transgenic chicken comprising an inactivated immunoglobulin gene |
AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
BR112018003778A2 (pt) * | 2015-08-27 | 2018-09-25 | Crystal Bioscience Inc | animal transgênico para produção de anticorpos que apresenta uma cadeia leve comum |
KR20200088805A (ko) * | 2017-09-19 | 2020-07-23 | 더 스테이트 오브 이스라엘, 미니스트리 오브 애그리컬처 & 루럴 디벨로프먼트, 애그리컬처럴 리서치 오거니제이션, (에이.알.오.), 볼카니 센터 | 게놈-편집 조류 |
CN110484549B (zh) * | 2018-04-20 | 2023-10-03 | 北京大学 | 基因组靶向修饰方法 |
CA3128360A1 (en) * | 2019-03-05 | 2020-09-10 | Yuval CINNAMON | Genome-edited birds |
WO2023127903A1 (ja) * | 2021-12-28 | 2023-07-06 | 国立大学法人北海道大学 | 始原生殖細胞が富化された胚を調製する方法 |
CN115120382A (zh) * | 2022-05-26 | 2022-09-30 | 广东省农业科学院动物科学研究所 | 一种鸡生殖前体细胞移植受体的制备方法 |
CN115191404B (zh) * | 2022-07-28 | 2023-04-21 | 四川省畜牧科学研究院 | 提高黄羽肉鸡后代公鸡比例的新品种选育方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999019472A1 (en) * | 1997-10-16 | 1999-04-22 | University Of Georgia Research Foundation, Inc. | Vectors comprising a magnum-specific promoter for avian transgenesis |
WO2006084035A2 (en) * | 2005-02-01 | 2006-08-10 | Origen Therapeutics, Inc. | Transgenic chickens |
US20060236418A1 (en) * | 2003-02-26 | 2006-10-19 | Babraham Institute | Genetically modified non-human mammals and cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1852925A (zh) * | 2003-07-15 | 2006-10-25 | 人类多克隆治疗公司 | 人源化免疫球蛋白基因座 |
-
2008
- 2008-08-14 CN CN200880111586A patent/CN101868144A/zh active Pending
- 2008-08-14 EP EP08797925A patent/EP2187732A4/en not_active Withdrawn
- 2008-08-14 KR KR1020107005724A patent/KR101563017B1/ko not_active IP Right Cessation
- 2008-08-14 CA CA2706224A patent/CA2706224A1/en not_active Abandoned
- 2008-08-14 WO PCT/US2008/073214 patent/WO2009023800A1/en active Application Filing
- 2008-08-14 AU AU2008286791A patent/AU2008286791A1/en not_active Abandoned
- 2008-08-14 JP JP2010521188A patent/JP5760159B2/ja not_active Expired - Fee Related
-
2014
- 2014-09-29 JP JP2014197988A patent/JP6004290B2/ja not_active Expired - Fee Related
-
2016
- 2016-04-14 JP JP2016080837A patent/JP2016129519A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999019472A1 (en) * | 1997-10-16 | 1999-04-22 | University Of Georgia Research Foundation, Inc. | Vectors comprising a magnum-specific promoter for avian transgenesis |
US20060075513A1 (en) * | 1997-10-16 | 2006-04-06 | Avigenics, Inc. | Avian transgenesis and exogenous proteins |
US20060236418A1 (en) * | 2003-02-26 | 2006-10-19 | Babraham Institute | Genetically modified non-human mammals and cells |
WO2006084035A2 (en) * | 2005-02-01 | 2006-08-10 | Origen Therapeutics, Inc. | Transgenic chickens |
Also Published As
Publication number | Publication date |
---|---|
KR20100088125A (ko) | 2010-08-06 |
JP5760159B2 (ja) | 2015-08-05 |
JP6004290B2 (ja) | 2016-10-05 |
EP2187732A4 (en) | 2012-11-07 |
AU2008286791A1 (en) | 2009-02-19 |
WO2009023800A1 (en) | 2009-02-19 |
JP2016129519A (ja) | 2016-07-21 |
CN101868144A (zh) | 2010-10-20 |
JP2014239702A (ja) | 2014-12-25 |
EP2187732A1 (en) | 2010-05-26 |
JP2010536346A (ja) | 2010-12-02 |
CA2706224A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101563017B1 (ko) | 불활성화된 내인성 유전자좌를 갖는 트랜스제닉 닭 | |
US20170223938A1 (en) | Transgenic chickens with an inactivated endogenous gene locus | |
KR20180091821A (ko) | 유전적 상보성에 의한 인간화 car t-세포 및 혈소판의 조작방법 | |
ES2615081T3 (es) | Cultivo a largo plazo de células germinales primordiales de pollo | |
JP2019502400A (ja) | キメラ胚補助臓器作製用の組成物及び方法 | |
JP6644276B2 (ja) | 家禽始原生殖細胞の遺伝子改変方法、遺伝子改変された家禽始原生殖細胞、遺伝子改変家禽の生産方法及び家禽卵 | |
US20220136003A1 (en) | Genome-edited birds | |
US20240052304A1 (en) | Sterile avian embryos, production and uses thereof | |
JP2017521079A (ja) | 生殖系列細胞を切除するnanosノックアウト | |
US20200214273A1 (en) | Genome-edited birds | |
US20210037797A1 (en) | Inducible disease models methods of making them and use in tissue complementation | |
KR20180128386A (ko) | 유전적 상보성에 의한 인간화 신장의 조작 | |
KR20210106412A (ko) | 유전적으로 변형된 불임 조류 및 이의 재구성 방법 | |
WO2024003907A1 (en) | Totally sterile population of avian embryos, production and uses thereof | |
EA043573B1 (ru) | Птицы с отредактированным геномом |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |